New Products: Inex Innovations Exchange's iGeneScreen | GenomeWeb

Singapore-based Inex Innovations Exchange has expanded its iGeneScreen noninvasive prenatal test to include fetal sex chromosome abnormalities, in addition to trisomy 21, 18, and 13. Inex developed its next-generation sequencing-based iGeneScreen test in collaboration with BGI.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.